![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
DJ Snyders and A Chaudhary
Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-6602, USA. dirk.snyders@mcmail.vanderbilt.edu
In the long QT syndrome, excessive prolongation of the cardiac action potential leads to polymorphic ventricular tachycardia (torsades de pointes) and sudden death. Mutations in HERG have been identified as one of the causes of the chromosome 7-linked form of congenital long QT syndrome. The biophysical properties of currents recorded from HERG expressing Xenopus oocytes are similar to those of a cardiac K+ current, I(Kr), but the characteristic nanomolar methanesulfonanilide sensitivity has not been demonstrated. To determine the biophysical and pharmacological properties of HERG under experimental conditions similar to those used to study native cardiac currents, we examined currents expressed after expression of HERG in a human cell line, human embryonic kidney 293. Transfected cells display K+-selective outward currents that activated at membrane potentials positive to -50 mV with strongly voltage-dependent kinetics [time constant (tau) = 2 sec at -20 mV and 188 msec at +20 mV]. Marked inward rectification was observed for depolarizations positive to +0 mV, which was due to rapid channel inactivation (tau = 6 msec at +50 mV). The subsequent tail currents at - 40 mV displayed an initial rising phase with tau = 10 msec, followed by a slow multiexponential decline. The EC50 for the methanesulfonanilide I(Kr) blocker dofetilide was 12 +/- 2 nM. Induction of block depended on depolarization beyond the threshold for channel opening. Time- dependent block developed slowly, with tau = 5.2 +/- 0.6 sec (300 nM) at +10 mV, and was delayed by stronger depolarizations. This pattern suggested that dofetilide preferentially blocks open (or activated) channels and that the fast inactivation may competitively slow the binding kinetics. The latter occurrence was further supported by a simplified mathematical model that addressed the impact on binding kinetics of fast inactivation. These results indicate that the HERG gene product encodes an alpha subunit that, when expressed in mammalian cells, displays both the major functional and pharmacological properties of native I(Kr). Dofetilide acts as a slow-onset/slow-offset open channel blocker of this current at nanomolar concentrations.
This article has been cited by other articles:
|
|
 |
|
  B. D. Guth Preclinical Cardiovascular Risk Assessment in Modern Drug Development Toxicol. Sci., May 1, 2007; 97(1): 4 - 20. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zeng, I. M. Lozinskaya, Z. Lin, R. N. Willette, D. P. Brooks, and X. Xu Mallotoxin Is a Novel Human Ether-a-go-go-Related Gene (hERG) Potassium Channel Activator J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 957 - 962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Guo, H. Gang, and S. Zhang Molecular Determinants of Cocaine Block of Human Ether-a-go-go-Related Gene Potassium Channels J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 865 - 874. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Gintant, Z. Su, R. L. Martin, and B. F. Cox Utility of hERG Assays as Surrogate Markers of Delayed Cardiac Repolarization and QT Safety Toxicol Pathol, January 1, 2006; 34(1): 81 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. V. Vasilyev, T. L. Merrill, and M. R. Bowlby Development of a Novel Automated Ion Channel Recording Method Using "Inside-Out" Whole-Cell Membranes J Biomol Screen, December 1, 2005; 10(8): 806 - 813. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Lin, J. Guo, H. Gang, P. Wojciechowski, J. T. Wigle, and S. Zhang Intracellular K+ Is Required for the Inactivation-Induced High-Affinity Binding of Cisapride to HERG Channels Mol. Pharmacol., September 1, 2005; 68(3): 855 - 865. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lin, X. Ke, I. Cvetanovic, V. Ranade, and J. Somberg The Influence of Extracellular Acidosis on the Effect of IKr Blockers Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2005; 10(1): 67 - 76. [Abstract] [PDF]
|
|
|
|
 |
|
 C. E. Clancy and R. S. Kass Inherited and Acquired Vulnerability to Ventricular Arrhythmias: Cardiac Na+ and K+ Channels Physiol Rev, January 1, 2005; 85(1): 33 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Berecki, J. G. Zegers, A. O. Verkerk, Z. A. Bhuiyan, B. de Jonge, M. W. Veldkamp, R. Wilders, and A. C. G. van Ginneken HERG Channel (Dys)function Revealed by Dynamic Action Potential Clamp Technique Biophys. J., January 1, 2005; 88(1): 566 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rezazadeh, J. C. Hesketh, and D. Fedida Rb+ Flux through hERG Channels Affects the Potency of Channel Blocking Drugs: Correlation with Data Obtained Using a High-Throughput Rb+ Efflux Assay J Biomol Screen, October 1, 2004; 9(7): 588 - 597. [Abstract] [PDF]
|
|
|
|
 |
|
 R. E. Garcia-Ferreiro, D. Kerschensteiner, F. Major, F. Monje, W. Stuhmer, and L. A. Pardo Mechanism of Block of hEag1 K+ Channels by Imipramine and Astemizole J. Gen. Physiol., September 27, 2004; 124(4): 301 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. L. Bett and R. L. Rasmusson Inactivation and recovery in Kv1.4 K+ channels: lipophilic interactions at the intracellular mouth of the pore J. Physiol., April 1, 2004; 556(1): 109 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Chandra, T. S. Rosen, Z.-H. Yeom, K. Lee, H.-Y. Kim, P. Danilo Jr, and M. R. Rosen Evaluation of KCB-328, a new IKr blocking antiarrhythmic agent in pacing induced canine atrial fibrillation Europace, January 1, 2004; 6(5): 384 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Crampin, M. Halstead, P. Hunter, P. Nielsen, D. Noble, N. Smith, and M. Tawhai Computational physiology and the physiome project Exp Physiol, January 1, 2004; 89(1): 1 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Diochot, E. Loret, T. Bruhn, L. Beress, and M. Lazdunski APETx1, a New Toxin from the Sea Anemone Anthopleura elegantissima, Blocks Voltage-Gated Human Ether-a-go-go-Related Gene Potassium Channels Mol. Pharmacol., July 1, 2003; 64(1): 59 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Bezzina, A. O. Verkerk, A. Busjahn, A. Jeron, J. Erdmann, T. T. Koopmann, Z. A. Bhuiyan, R. Wilders, M. M.A.M. Mannens, H. L. Tan, et al. A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization Cardiovasc Res, July 1, 2003; 59(1): 27 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ishii, M. Nagai, M. Takahashi, and M. Endoh Dissociation of E-4031 from the HERG channel caused by mutations of an amino acid results in greater block at high stimulation frequency Cardiovasc Res, March 1, 2003; 57(3): 651 - 659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Shoeb, A. P. Malykhina, and H. I. Akbarali Cloning and Functional Characterization of the Smooth Muscle Ether-a-go-go-related Gene K+ Channel. POTENTIAL ROLE OF A CONSERVED AMINO ACID SUBSTITUTION IN THE S4 REGION J. Biol. Chem., January 17, 2003; 278(4): 2503 - 2514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Li, G. C. L. Bett, X. Jiang, V. E. Bondarenko, M. J. Morales, and R. L. Rasmusson Regulation of N- and C-type inactivation of Kv1.4 by pHo and K+: evidence for transmembrane communication Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H71 - H80. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wang, K. Della Penna, H. Wang, J. Karczewski, T. M. Connolly, K. S. Koblan, P. B. Bennett, and J. J. Salata Functional and pharmacological properties of canine ERG potassium channels Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H256 - H267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Bauman and R. J. DiDomenico Cocaine-Induced Channelopathies: Emerging Evidence on the Multiple Mechanisms of Sudden Death Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2002; 7(3): 195 - 202. [Abstract] [PDF]
|
|
|
|
|
|
J.-B. Park, H. Choe, Y.-K. Lee, K.-C. Ha, K.-S. Rhee, J.-K. Ko, C.-U. Joo, S.-W. Chae, and Y.-G. Kwak Open Channel Block by KCB-328 [1-(2-Amino-4-methanesulfonamidophenoxy)-2-[N-(3,4-dimethoxyphenethyl)-N-methylamino]ethane Hydrochloride] of the Heterologously Expressed Human Ether-a-go-go-Related Gene K+ Channels J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 314 - 319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Volberg, B. J. Koci, W. Su, J. Lin, and J. Zhou Blockade of Human Cardiac Potassium Channel Human Ether-a-go-go-Related Gene (HERG) by Macrolide Antibiotics J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 320 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Gong, C. L. Anderson, C. T. January, and Z. Zhou Role of glycosylation in cell surface expression and stability of HERG potassium channels Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H77 - H84. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Sanchez-Chapula, R. A. Navarro-Polanco, C. Culberson, J. Chen, and M. C. Sanguinetti Molecular Determinants of Voltage-dependent Human Ether-a-Go-Go Related Gene (HERG) K+ Channel Block J. Biol. Chem., June 21, 2002; 277(26): 23587 - 23595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ottschytsch, A. Raes, D. Van Hoorick, and D. J. Snyders Obligatory heterotetramerization of three previously uncharacterized Kv channel alpha -subunits identified in the human genome PNAS, June 11, 2002; 99(12): 7986 - 7991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lecchi, E. Redaelli, B. Rosati, G. Gurrola, T. Florio, O. Crociani, G. Curia, R. R. Cassulini, A. Masi, A. Arcangeli, et al. Isolation of a Long-Lasting eag-Related Gene-Type K+ Current in MMQ Lactotrophs and Its Accommodating Role during Slow Firing and Prolactin Release J. Neurosci., May 1, 2002; 22(9): 3414 - 3425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E O'Leary Inhibition of HERG potassium channels by cocaethylene: a metabolite of cocaine and ethanol Cardiovasc Res, January 1, 2002; 53(1): 59 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Ficker, W. Jarolimek, and A. M. Brown Molecular Determinants of Inactivation and Dofetilide Block in ether a-go-go (EAG) Channels and EAG-Related K+ Channels Mol. Pharmacol., December 1, 2001; 60(6): 1343 - 1348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Zhang, S. Rajamani, Y. Chen, Q. Gong, Y. Rong, Z. Zhou, A. Ruoho, and C. T. January Cocaine Blocks HERG, but Not KvLQT1+minK, Potassium Channels Mol. Pharmacol., April 16, 2001; 59(5): 1069 - 1076. [Abstract] [Full Text]
|
|
|
|
|
|
M. E. O'Leary Inhibition of Human Ether-A-Go-Go Potassium Channels by Cocaine Mol. Pharmacol., February 1, 2001; 59(2): 269 - 277. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. Numaguchi, F. M. Mullins, J. P. Johnson Jr., D. C. Johns, S. S. Po, I. C.-H. Yang, G. F. Tomaselli, and J. R. Balser Probing the Interaction Between Inactivation Gating and Dd-Sotalol Block of HERG Circ. Res., November 24, 2000; 87(11): 1012 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Secondo, M. Taglialatela, M. Cataldi, G. Giorgio, M. Valore, G. Di Renzo, and L. Annunziato Pharmacological Blockade of ERG K+ Channels and Ca2+ Influx through Store-Operated Channels Exerts Opposite Effects on Intracellular Ca2+ Oscillations in Pituitary GH3 Cells Mol. Pharmacol., November 1, 2000; 58(5): 1115 - 1128. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Katayama, A. Fujita, T. Ohe, I. Findlay, and Y. Kurachi Inhibitory Effects of Vesnarinone on Cloned Cardiac Delayed Rectifier K+ Channels Expressed in a Mammalian Cell Line J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 339 - 346. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. L. Overholt, E. Ficker, T. Yang, H. Shams, G. R. Bright, and N. R. Prabhakar HERG-Like Potassium Current Regulates the Resting Membrane Potential in Glomus Cells of the Rabbit Carotid Body J Neurophysiol, March 1, 2000; 83(3): 1150 - 1157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Pond, B. K. Scheve, A. T. Benedict, K. Petrecca, D. R. Van Wagoner, A. Shrier, and J. M. Nerbonne Expression of Distinct ERG Proteins in Rat, Mouse, and Human Heart. RELATION TO FUNCTIONAL IKr CHANNELS J. Biol. Chem., February 25, 2000; 275(8): 5997 - 6006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Lees-Miller, Y. Duan, G. Q. Teng, and H. J. Duff Molecular Determinant of High-Affinity Dofetilide Binding to HERG1 Expressed in Xenopus Oocytes: Involvement of S6 Sites Mol. Pharmacol., February 1, 2000; 57(2): 367 - 374. [Abstract] [Full Text]
|
|
|
|
|
|
H.-Z. Wang, H. Shi, S.-J. Liao, and Z. Wang Inactivation gating determines nicotine blockade of human HERG channels Am J Physiol Heart Circ Physiol, September 1, 1999; 277(3): H1081 - H1088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Zhang, Z. Zhou, Q. Gong, J. C. Makielski, and C. T. January Mechanism of Block and Identification of the Verapamil Binding Domain to HERG Potassium Channels Circ. Res., May 14, 1999; 84(9): 989 - 998. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. B. GURROLA, B. ROSATI, M. ROCCHETTI, G. PIMIENTA, A. ZAZA, A. ARCANGELI, M. OLIVOTTO, L. D. POSSANI, and E. WANKE A toxin to nervous, cardiac, and endocrine ERG K+ channels isolated from Centruroides noxius scorpion venom FASEB J, May 1, 1999; 13(8): 953 - 962. [Abstract] [Full Text]
|
|
|
|
|
|
D. J Snyders Structure and function of cardiac potassium channels Cardiovasc Res, May 1, 1999; 42(2): 377 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Trudeau, S. A. Titus, J. L. Branchaw, B. Ganetzky, and G. A. Robertson Functional Analysis of a Mouse Brain Elk-Type K+ Channel J. Neurosci., April 15, 1999; 19(8): 2906 - 2918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kupershmidt, D. J. Snyders, A. Raes, and D. M. Roden A K+ Channel Splice Variant Common in Human Heart Lacks a C-terminal Domain Required for Expression of Rapidly Activating Delayed Rectifier Current J. Biol. Chem., October 16, 1998; 273(42): 27231 - 27235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Chouabe, M.-D. Drici, G. Romey, J. Barhanin, and M. Lazdunski HERG and KvLQT1/IsK, the Cardiac K+ Channels Involved in Long QT Syndromes, Are Targets for Calcium Channel Blockers Mol. Pharmacol., October 1, 1998; 54(4): 695 - 703. [Abstract] [Full Text]
|
|
|
|
|
|
Z. Zhou, Q. Gong, M. L. Epstein, and C. T. January HERG Channel Dysfunction in Human Long QT Syndrome. INTRACELLULAR TRANSPORT AND FUNCTIONAL DEFECTS J. Biol. Chem., August 14, 1998; 273(33): 21061 - 21066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Rampe, M. K. Murawsky, J. Grau, and E. W. Lewis The Antipsychotic Agent Sertindole is a High Affinity Antagonist of the Human Cardiac Potassium Channel HERG J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 788 - 793. [Abstract] [Full Text]
|
|
|
|
|
|
W.-P. Yang, P. C. Levesque, W. A. Little, M. L. Conder, P. Ramakrishnan, M. G. Neubauer, and M. A. Blanar Functional Expression of Two KvLQT1-related Potassium Channels Responsible for an Inherited Idiopathic Epilepsy J. Biol. Chem., July 31, 1998; 273(31): 19419 - 19423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Ficker, W. Jarolimek, J. Kiehn, A. Baumann, and A. M. Brown Molecular Determinants of Dofetilide Block of HERG K+ Channels Circ. Res., February 23, 1998; 82(3): 386 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Shi, R. S. Wymore, H.-S. Wang, Z. Pan, I. S. Cohen, D. McKinnon, and J. E. Dixon Identification of Two Nervous System-Specific Members of the erg Potassium Channel Gene Family J. Neurosci., December 15, 1997; 17(24): 9423 - 9432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Lees-Miller, C. Kondo, L. Wang, and H. J. Duff Electrophysiological Characterization of an Alternatively Processed ERG K+ Channel in Mouse and Human Hearts Circ. Res., November 19, 1997; 81(5): 719 - 726. [Abstract] [Full Text]
|
|
|
|
|
|
B. London, M. C. Trudeau, K. P. Newton, A. K. Beyer, N. G. Copeland, D. J. Gilbert, N. A. J enkins, C. A. Satler, and G. A. Robertson Two Isoforms of the Mouse Ether-a-go-go–Related Gene Coassemble to Form Channels With Properties Similar to the Rapidly Activating Component of the Cardiac Delayed Rectifier K+ Current Circ. Res., November 19, 1997; 81(5): 870 - 878. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Toyama, K. Kamiya, J. Cheng, J.-K. Lee, R. Suzuki, and I. Kodama Vesnarinone Prolongs Action Potential Duration Without Reverse Frequency Dependence in Rabbit Ventricular Muscle by Blocking the Delayed Rectifier K+ Current Circulation, November 18, 1997; 96(10): 3696 - 3703. [Abstract] [Full Text]
|
|
|
|
|
|
S. Mohammad, Z. Zhou, Q. Gong, and C. T. January Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride Am J Physiol Heart Circ Physiol, November 1, 1997; 273(5): H2534 - H2538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Taglialatela, P. Castaldo, S. Iossa, A. Pannaccione, A. Fresi, E. Ficker, and L. Annunziato Regulation of the human ether-a-gogo related gene (HERG) K+ channels by reactive oxygen species PNAS, October 14, 1997; 94(21): 11698 - 11703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Fiset, B. Drolet, B. A. Hamelin, and J. Turgeon Block of IKs by the Diuretic Agent Indapamide Modulates Cardiac Electrophysiological Effects of the Class III Antiarrhythmic Drug dl-Sotalol J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 148 - 156. [Abstract] [Full Text]
|
|
|
|
|
|
T. Yang, D. J. Snyders, and D. M. Roden Rapid Inactivation Determines the Rectification and [K+]o Dependence of the Rapid Component of the Delayed Rectifier K+ Current in Cardiac Cells Circ. Res., June 19, 1997; 80(6): 782 - 789. [Abstract] [Full Text]
|
|
|
|
|
|
W.-P. Yang, P. C. Levesque, W. A. Little, M. L. Conder, F. Y. Shalaby, and M. A. Blanar KvLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias PNAS, April 15, 1997; 94(8): 4017 - 4021. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yang, D. J. Snyders, and D. M. Roden Inhibition of Cardiac Potassium Currents by the Vesnarinone Analog OPC-18790: Comparison with Quinidine and Dofetilide J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1170 - 1175. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
